Answers are grounded in this paper and cite their sources.
OBJECTIVES: anti-MDA5 test. METHODS: anti-MDA5 test side-by-side. For the commercial ELISA kit, serum samples diluted 1:101 were used according to the manufacturer's protocol, but serial dilutions of sera were also examined to identify the optimal serum dilution for quantification. RESULTS: anti-MDA5 test, including a better correlation with the in-house ELISA results and an increased sensitivity to change. CONCLUSION: We improved the ability of the commercial ELISA kit to quantify anti-MDA5 antibody titer by altering its protocol.
No takes yet. Share an insight, caveat, or question.
Gono et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: